Year of Award
2025
Document Type
Professional Paper
Degree Type
Master of Science (MS)
Other Degree Name/Area of Focus
Neuroscience
Department or School/College
Molecular and Biomedical Sciences
Committee Chair
Kasper Hansen
Committee Co-chair
Sarah Certel
Commitee Members
Kasper Hansen, Andrew Rau, Katie Holick
Keywords
Neuroscience, ion channel, drug discovery, neuropharmacology, positive modulation
Subject Categories
Biochemistry, Biophysics, and Structural Biology | Neuroscience and Neurobiology | Pharmacy and Pharmaceutical Sciences
Abstract
N-methyl-D-aspartate (NMDA) receptors are ionotropic glutamate receptors that mediate excitatory neurotransmission in the central nervous system (CNS) where they play critical roles in normal and pathological brain functions and neurodevelopment. While the glutamate/glycineactivated GluN2-containing NMDA receptors (GluN1/GluN2) have been extensively studied, the physiological roles and pharmacology of glycine-activated GluN3-containing receptors (GluN1/GluN3) remain less understood. Although GluN1/GluN3 receptors exhibit unique functional properties and play distinct roles in neuronal development and synapse maturation, studies of their precise roles in neurophysiology and circuit function are impeded by limited availability of GluN3-selective pharmacological tools. This study describes UCM-A86, a novel GluN3-selective positive allosteric modulator, with EC50 values of 18 µM and 20 µM at GluN1/GluN3A and GluN1/GluN3B receptors, respectively. UCM-A86 selectively potentiates recombinant GluN1/GluN3A and GluN1/GluN3B receptors by 431% and 155%, respectively, relative to activation by glycine, with no activity at recombinant GluN1/GluN2A-D receptors. Furthermore, UCM-A86 selectively potentiates responses from native GluN1/GluN3A receptors expressed in somatostatin-expressing interneurons of the somatosensory cortex with no modulation of hippocampal AMPA receptor- and GluN1/2 NMDA receptor-mediated excitatory postsynaptic currents. Mechanistic studies suggest that UCM-A86 modulation is facilitated by agonist binding (or channel gating) and that UCM-A86 primarily potentiates GluN1/GluN3A by increasing open probability with no effects on mean channel conductance. These findings advance the synthetic pharmacology of GluN1/GluN3 receptors and provide a novel tool for modulation of native GluN3-containing NMDA receptors.
Recommended Citation
Johns, Mia Ruth, "Positive allosteric modulation of GluN1/GluN3 NMDA receptors" (2025). Graduate Student Theses, Dissertations, & Professional Papers. 12538.
https://scholarworks.umt.edu/etd/12538
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Neuroscience and Neurobiology Commons, Pharmacy and Pharmaceutical Sciences Commons
© Copyright 2025 Mia Ruth Johns